Results 161 to 170 of about 5,401 (177)

Enhanced skin delivery of vismodegib by microneedle treatment

Drug Delivery and Translational Research, 2015
Hiep X Nguyen, Ajay K Banga, Banga Ajay K   +2 more
exaly  

A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma

Journal of the American Academy of Dermatology, 2015
Howard Sofen, Tiffani K Hamilton
exaly  

Nanoformulation for potential topical delivery of Vismodegib in skin cancer treatment

International Journal of Pharmaceutics, 2019
Maria Natalia Calienni, Christian Zevallos-Delgado, Donatella Paolino   +2 more
exaly  

Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib

Journal of the American Academy of Dermatology, 2014
Anne Lynn S Chang, James A Solomon, Leonard Goldberg   +2 more
exaly  

Vismodegib

Reactions Weekly, 2016
  +5 more sources

Pilomatricomas secondary to treatment with vismodegib

JAAD Case Reports, 2019
Jorge Magdaleno-Tapial, Cristian Valenzuela-Oñate, Blanca Ferrer-Guillén   +2 more
exaly  

Polymeric micelle nanocarriers for targeted epidermal delivery of the hedgehog pathway inhibitor vismodegib: formulation development and cutaneous biodistribution in human skin

Expert Opinion on Drug Delivery, 2019
Mayank Singhal, Yogeshvar N Kalia
exaly  

Discovery and preclinical development of vismodegib

Expert Opinion on Drug Discovery, 2014
Stephen E Gould, Jennifer A Low, James C Marsters   +2 more
exaly  

Amenorrhea secondary to a vismodegib-induced blockade of follicle-stimulating hormone–receptor activation

Fertility and Sterility, 2014
John Strasswimmer
exaly  

Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug–drug interaction potential

Cancer Chemotherapy and Pharmacology, 2012
Sarina A Piha-Paul, A Dimitrios Colevas, Jennifer A Low   +2 more
exaly